ArticleAAPS PharmSciTech2026
Multi-Objective Spray Drying Process Optimization via BBD-ANN-AGWO Framework: Case of Andrographolide Amorphous Solid Dispersions.
Article in AAPS PharmSciTech, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Liquisolid Technology Improves and Reduces Source-Dependent Variability in Andrographolide Dissolution fromPharmaceutics · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study aims to establish a multi-objective spray drying process optimization framework, with andrographolide (ADG) amorphous solid dispersion serving as a model drug. The proposed framework integrates Box-Behnken design (BBD), artificial neural networks (ANN), and an adaptive grey wolf optimizer (AGWO). Molecular docking was employed to screen potential polymeric carriers, and in vitro dissolution experiments were conducted to identify the carrier with the best solubilizing performance. Single-factor experiment and BBD trial were carried out to evaluate the effects of key process parameters on energy consumption, drying loss, drug release, and yield. A multi-response ANN model was then developed based on BBD data. To enhance the model's generalization ability and account for process variability, virtual samples were introduced to augment the training dataset. AGWO was subsequently applied to perform inverse optimization and identify the optimal process parameter combination. Experimental validation demonstrated good agreement with the model predictions. X-ray diffraction analysis (XRD) and Fourier-transform infrared (FT-IR) analyses confirmed the amorphous transformation of ADG and its satisfactory short-term physical stability. The proposed method provides a feasible and intelligent strategy for multi-objective optimization in pharmaceutical formulation development.
Indexed as
Identifiers
41741879What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.